e-learning
resources
Paris 2018
Monday, 17.09.2018
COPD, asthma and tuberculosis: benefits related to therapy costs
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Costs of COPD exacerbations in a general population.
M. Erdal (Bergen, Norway), A. Johannessen (Bergen, Norway), T. Eagan (Bergen, Norway), P. Bakke (Bergen, Norway), A. Gulsvik (Bergen, Norway), J. Askildsen (Bergen, Norway), R. Grønseth (Bergen, Norway)
Source:
International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Session:
COPD, asthma and tuberculosis: benefits related to therapy costs
Session type:
Thematic Poster
Number:
3157
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Erdal (Bergen, Norway), A. Johannessen (Bergen, Norway), T. Eagan (Bergen, Norway), P. Bakke (Bergen, Norway), A. Gulsvik (Bergen, Norway), J. Askildsen (Bergen, Norway), R. Grønseth (Bergen, Norway). Costs of COPD exacerbations in a general population.. 3157
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
COPD exacerbations and predictors in a general population
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Costs of exacerbations in COPD
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012
The costs of exacerbations in COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 273s
Year: 2001
How common is exacerbations in COPD in a general population sample?
Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD
Year: 2010
COPD exacerbations occur more frequently in women – Data from the Bergmannsheil cohort
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
A global survey conducted to determine frequency of exacerbations in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Incidence of asthma and COPD in a general population
Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD
Year: 2010
Hospitalization cost analysis due to acute COPD exacerbations
Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system
Year: 2016
Analysis of the frequency of COPD exacerbations in the ’real-life’ DACCORD study over a 2 year period
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Costs of COPD and asthma in Sweden
Source: Eur Respir J 2004; 24: Suppl. 48, 701s
Year: 2004
The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Outpatient care for reducing readmissions of patients hospitalized for exacerbation of COPD
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Frequency of COPD exacerbations and severity of COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
A self-treatment programme in patients with COPD: Effectiveness for the reduction of severe exacerbations
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
Antibiotics prescriptions increased medical costs for COPD exacerbations.
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019
Statin use and risk of exacerbations in individuals with COPD: The Copenhagen general population study
Source: International Congress 2014 – New insights into the epidemiology of COPD
Year: 2014
COPD care programme can reduce readmissions and in-patient bed days
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Factors associated with COPD exacerbation frequency in a UK primary care cohort
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept